58TWENTYFOURSEVENBIOPHARMA Issue 1 / March 2026 The global Al in healthcare market is projected to reach USD 110,611.6 million by 2030 from USD 21,633.7 million in 2025, at a CAGR of 38.6%. The increasing prevalence of chronic diseases, coupled with a growing geriatric population, is placing significant financial pressure on healthcare providers. This has led to a heightened need for early detection of conditions such as dementia and cardiovascular disorders through the analysis of imaging data. Healthcare professionals can develop personalized treatment plans by identifying patterns in these images. Additionally, there is a rising demand for advanced health services that leverage artificial intelligence (AI), machine learning (ML), and data analytics. Government support through funding and investment across various regions has further stimulated awareness of diagnostic imaging among individuals. These factors collectively contribute to the growing adoption of Al tools within the healthcare industry. AI in healthcare market: ecosystem mapping Al-based tools can significantly reduce healthcare spending by minimizing manual labor and addressing inefficiencies in care delivery, overtreatment, and improper care. They streamline operations and improve precision in resource allocation, thus contributing to a more efficient and cost-effective healthcare ecosystem. The Al in healthcare market has experienced a significant surge in growth and is poised for further expansion in the coming years. In healthcare, Al focuses on the use of algorithms and software to approximate human cognition in the analysis of complex medical data. The primary aim of health-related Al applications is to analyse relationships between prevention or treatment techniques and patient outcomes. A few major application areas of Al programs in healthcare are centered on practices such as diagnosis processes, treatment protocol development, personalized medicine, and patient monitoring and care. Early disease detection plays a crucial role in reducing mortality rates, as diagnosing diseases at an early stage significantly improves survival outcomes and lowers treatment costs. However, in many resourcepoor settings, chronic diseases are often diagnosed at a late stage, leading to lower survival rates, greater morbidity, and higher treatment expenses. Even in countries with strong healthcare systems, many ARTIFICIAL INTELLIGENCE
RkJQdWJsaXNoZXIy MjY2OTA4MA==